Company / Gross Profit per Share
Niagen Bioscience, Inc. Gross Profit per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$1.08
FY2025
5-year range
$0.57 / $1.08
FY2021-FY2025
Trend
+58.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has fluctuated over the past 10 years, ranging from $0.19 in FY2018 to $467.77 in FY2019.
Based on SEC 10-K filings.
1.08 in FY2025 with a 5-year CAGR of +20.0%.
Improved from $0.57 to $1.08 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +20.9%
- 5-Year CAGR
- +20.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit per share increased 58.8% year-over-year.
- Peak gross profit per share was recorded in FY2019.
- Lowest gross profit per share in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.08 | +58.8% |
| FY2024 | $0.68 | +18.0% |
| FY2023 | $0.57 | -5.8% |
| FY2022 | $0.61 | +6.8% |
| FY2021 | $0.57 | +31.8% |
| FY2020 | $0.43 | -99.9% |
| FY2019 | $467.77 | +244107.6% |
| FY2018 | $0.19 | -31.4% |
| FY2017 | $0.28 | -3.3% |
| FY2016 | $0.29 | +303.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026